Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Preliminary Results

16 Feb 2009 07:50

RNS Number : 3538N
Steppe Cement Limited
16 February 2009
 



Steppe Cement Limited

Preliminary results for the year ended 31 December 2008 

The Group recorded turnover for the year ended 31 December 2008 of 11,012 million Tenge from cement sales totalling 807,300 tonnes. This compares with 12,150 million Tenge and cement sales of 820,287 tonnes for the year ended 31 December 2007. The recent devaluation from 120 Tenge/US$ to 150Tenge/US$ will have an adverse impact on the financial obligations of the Group with US$61 million of medium term and long term debt being serviced by operational cash flow almost exclusively denominated in Tenge. One positive consequence of the devaluation will be to make the domestic market less attractive to cement importers. The global financial credit squeeze has affected the ability of Kazakh banks to provide customary lines of credit to the commercial, industrial and residential development sectors and the effects of this on the Kazakh economy have impacted upon the Group's trading during the second half of 2008. To counter this negative influence on the local economy the Kazakh Government has recently announced a series of significant investments in infrastructure, particularly in the centre and north of Kazakhstan. It is expected that the Group will benefit from these initiatives as these are implemented in the latter half of 2009 and subsequent years.

With the commissioning of line 6, Steppe Cement has a total annual capacity of 1.6 million tonnes per annum which the Board consider sufficient to meet likely demand in 2009. In the circumstances, the Board has decided to defer the finalisation of the refurbishment of line 5 until it has more visibility on the size of the market. All the main equipment required for the refurbishment has already been imported and is on site with approximately US$25 million required to complete the project.

The Board does not expect to propose that the Company does pay a dividend during 2009, with positive operational cash flows being intended to be applied to further improvements to line 6 and debt reduction in 2010 and subsequent years. The full results and audited accounts denominated in US$ will be published in April 2009.

The Company's Nominated Adviser is RFC Corporate Finance Ltd.

Contact: Stephen Allen or Trinity McIntyre, ph: +61 8 9480 2500. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGRGDDBXBGGCL
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
27th May 20267:00 amRNSAnnual Financial Report
10th Apr 20267:00 amRNSTrading Update for the Quarter ended 31 March 2026
19th Jan 20268:03 amRNSInvestor Presentation via Investor Meet Company
15th Jan 20263:02 pmRNSReplacement - Trading Update
15th Jan 202610:45 amRNSTrading Update, Board Changes and Investment Plan
29th Dec 20257:00 amRNSCapital Repayment Payment Date
29th Dec 20257:00 amRNSCapital Repayment Payment Date
9th Dec 202510:30 amRNSCapital Repayment Record Date
5th Dec 20259:17 amRNSResult of EGM
14th Nov 20257:00 amRNSProposed Reduction & Repayment of Capital and EGM
17th Oct 20257:00 amRNSTrading Update for Q3 2025
15th Sep 20257:00 amRNSHalf-year Report
25th Jul 202511:07 amRNSResult of AGM
21st Jul 20251:34 pmRNSAGM – Submission of Shareholder Questions
7th Jul 20258:00 amRNSTrading Update
26th Jun 20257:55 amRNSNotice of AGM
26th Jun 20257:54 amRNSAnnual Financial Report
8th Apr 20258:29 amRNSTrading update for the quarter ended 31 March 2025
14th Jan 20257:00 amRNSYear End Trading Update
2nd Jan 202510:00 amRNSCapital Repayment Payment
12th Dec 20247:00 amRNSCapital Repayment Record Date
6th Dec 20248:39 amRNSResult of EGM
15th Nov 20247:00 amRNSProposed Reduction & Repayment of Capital and EGM
14th Oct 20247:00 amRNSTrading Update for Q3 2024
4th Oct 20249:15 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSHalf-year Report
6th Aug 20248:21 amRNSDirector's Dealing
2nd Aug 20249:44 amRNSDirector's Dealing
12th Jul 202410:08 amRNSResult of AGM and Market Update for H1 2024
4th Jul 20247:00 amRNSAGM - Submission of Shareholder Questions
19th Jun 20247:00 amRNSNotice of AGM
19th Jun 20247:00 amRNSAnnual Financial Report
23rd May 20247:00 amRNSCapital Repayment Record Date
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions
9th Jun 20237:00 amRNSNotice of AGM
9th Jun 20237:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.